Aspen Aerogels shareholders approve doubling of authorized shares to 250M and 2023 equity plan

ASPEN AEROGELS INC

Shareholders approved amendment increasing authorized common shares from 125M to 250M (48.8M for, 13.3M against).
Approved the 2023 Equity Incentive Plan authorizing 3M new shares plus rollover from prior plan (35.1M for, 9.2M against).
Approved officer exculpation amendment under new Delaware law (40.8M for, 4.5M against).
Directors Steven R. Mitchell and Donald R. Young reelected as Class III directors until 2026 annual meeting.
Director Richard F. Reilly's term ended at the annual meeting; no replacement named.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.95

ASPEN AEROGELS INC: Stockholders approved amendments to the Certificate of Incorporation to add officer exculpation provisions under new Delaware law and to increase authorized common shares from 125,000,000 to 250,000,000 (effective 2023-06-01).

Change: charter amendment
Effective: 2023-06-01

Exact text from the filing

The Amendments became effective upon the Company’s filing of a Certificate of Amendment to the Certificate of Incorporation with the Secretary of State of Delaware on June 1, 2023 (the “Certificate of Amendment”).

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.7

ASPEN AEROGELS INC shareholders approved Approval of the Aspen Aerogels 2023 Equity Incentive Plan at the 2023-06-01 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2023-06-01

Exact text from the filing

the Company’s stockholders approved the adoption of the Aspen Aerogels 2023 Equity Incentive Plan

View on SEC.gov

82 governance changes filed in the last 30 days. Browse all governance changes →

ASPEN AEROGELS INC filing history →

Source: SEC EDGAR

accession 0000950170-23-025706

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.